Walsh, Sinéad <br/><br/>
Loss of cannabinoid CB1 receptor expression in the 6-hydroxydopamine-induced nigrostriatal terminal lesion model of Parkinson's disease in the rat.  [electronic resource] 

 -  Brain research bulletin  Apr 2010 
 - 543-8 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1873-2747 
<br/><br/><label>Standard No.: </label>10.1016/j.brainresbull.2010.01.009  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adrenergic Agents--toxicity<br/>Animals<br/>Axons--drug effects<br/>Corpus Striatum--drug effects<br/>Disease Models, Animal<br/>Gene Expression<br/>Male<br/>Medial Forebrain Bundle--drug effects<br/>Nerve Degeneration--chemically induced<br/>Neurons--drug effects<br/>Organ Size<br/>Oxidopamine--toxicity<br/>Parkinson Disease<br/>Parkinsonian Disorders--chemically induced<br/>Random Allocation<br/>Rats<br/>Receptor, Cannabinoid, CB1--genetics<br/>Substantia Nigra--metabolism<br/>Time Factors<br/>Tyrosine 3-Monooxygenase--metabolism